Automated digital volume measurement of melanoma metastases in sentinel nodes predicts disease recurrence and survival

Histopathology

Volumn 59, Issue 3, 2011, Pages 433-440

  Riber Hansen, Rikke ^a   Nyengaard, Jens R ^b   Hamilton Dutoit, Stephen J ^a   Sjoegren, Pia ^a   Steiniche, Torben ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Digital image analysis; Melanoma; Neoplasm metastasis; Pathology; Sentinel lymph node biopsy; Stereology; Tumour burden

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; DIGITAL IMAGING; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE METASTASIS; STEREOLOGY; THICKNESS; TOTAL METASTATIC VOLUME;

DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

TOBACCO MOSAIC VIRUS;

EID: 80053338555     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03960.x     Document Type: Article

References (26)

1. van der Ploeg AP, van Akkooi AC, Schmitz PI, Koljenovic S, Verhoef C, Eggermont AM. EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria. Eur. J. Cancer 2010; 46; 2414-2421.
2. Starz H, Balda BR, Kramer KU, Buchels H, Wang H. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001; 91; 2110-2121.
3. Ranieri JM, Wagner JD, Azuaje R et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann. Surg. Oncol. 2002; 9; 975-981.
4. Govindarajan A, Ghazarian DM, McCready DR, Leong WL. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann. Surg. Oncol. 2007; 14; 906-912.
5. Satzger I, Volker B, Al GM, Meier A, Kapp A, Gutzmer R. Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology 2007; 50; 764-772.
6. Debarbieux S, Duru G, Dalle S, Beatrix O, Balme B, Thomas L. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Br. J. Dermatol. 2007; 157; 58-67.
7. Scheri RP, Essner R, Turner RR, Ye X, Morton DL. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann. Surg. Oncol. 2007; 14; 2861-2866.
8. Pearlman NW, McCarter MD, Frank M et al. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Am. J. Surg. 2006; 192; 878-881.
9. Rossi CR, De Salvo GL, Bonandini E et al. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node. Ann. Surg. Oncol. 2008; 15; 1202-1210.
10. Guggenheim M, Dummer R, Jung FJ et al. The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma-a retrospective analysis of 392 cases. Br. J. Cancer 2008; 98; 1922-1928.
11. Gershenwald JE, Andtbacka RH, Prieto VG et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J. Clin. Oncol. 2008; 26; 4296-4303.
12. Riber-Hansen R, Nyengaard JR, Hamilton-Dutoit SJ, Sjoegren P, Steiniche T. Metastatic melanoma volume in sentinel nodes: objective stereology-based measurement predicts disease recurrence and survival. Histopathology 2009; 54; 796-803.
13. European Organization for Research and Treatment of Cancer (EORTC). MINITUB Registration Study. Accessed August 20 2011.
14. Cserni G, Bianchi S, Boecker W et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 2005; 103; 358-367.
15. Cserni G, Sapino A, Decker T. Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting. Breast 2006; 15; 347-354.
16. Turner RR, Weaver DL, Cserni G et al. Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. J. Clin. Oncol. 2008; 26; 258-263.
17. Murali R, Cochran AJ, Cook MG et al. Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma. Cancer 2009; 115; 5026-5037.
18. Riber-Hansen R, Nyengaard JR, Hamilton-Dutoit SJ, Steiniche T. Stage migration after minor changes in histologic estimation of tumor burden in sentinel lymph nodes: the protocol trap. Cancer 2009; 115; 2177-2187.
19. Gundersen HJ. The nucleator. J. Microsc. 1988; 151; 3-21.
20. Gundersen HJ, Bendtsen TF, Korbo L et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988; 96; 379-394.
21. Dorph-Petersen KA, Nyengaard JR, Gundersen HJ. Tissue shrinkage and unbiased stereological estimation of particle number and size. J. Microsc. 2001; 204; 232-246.
22. Bruel A, Christoffersen TE, Nyengaard JR. Growth hormone increases the proliferation of existing cardiac myocytes and the total number of cardiac myocytes in the rat heart. Cardiovasc. Res. 2007; 76; 400-408.
23. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1; 307-310.
24. Riber-Hansen R, Sjoegren P, Hamilton-Dutoit SJ, Steiniche T. Extensive pathological analysis of selected melanoma sentinel lymph nodes: high metastasis detection rates at reduced workload. Ann. Surg. Oncol. 2008; 15; 1492-1501.
25. van Akkooi A, de WJ, Verhoef C et al. Clinical relevance of melanoma micrometastases (<0.1mm) in sentinel nodes: are these nodes to be considered negative? Ann. Oncol. 2006; 17; 1578-1585.
26. Dewar DJ, Newell B, Green MA, Topping AP, Powell BW, Cook MG. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J. Clin. Oncol. 2004; 22; 3345-3349.